Study Group: Physicians who Treat End Stage Renal Disease (ESRD)(?)
Council Members in this Study Group: 102
Request a survey with this Study Group
Leading Experts in this Study Group
Jeffrey Ballard, MD, FACSVascular Surgeon
St.joseph Hospital of Orange Inc.
Jeffrey Ballard, MD, FACS, is a Vascular and Endovascular Surgeon who practices at St. Joseph Hospital of Orange, California. He also has a appointment as Clinical Professor of Surgery at University of California, Irvine. Dr. Ballard offers comprehensive care for all problems of arterial and venous...
President
Dialysis Mgmt Inc.
Larry Day is the President of Dialysis Management, Inc. He is an expert in the area of renal dialysis, and nephrology business management. Mr. Day is knowledgeable on reimbursement and clinical areas. He has over 31 years of experience in this field. Mr. Day has done seminars for over 20 years and has...
Jeffrey Gosin, M.D.Attending Surgeon and Chief of Vascular Surgery
Shore Memorial Hospital
Jeffrey Gosin, MD, is a Vascular and General Surgeon with Jersey Shore Surgical Group in New Jersey. He is an Attending Surgeon and Chief of Vascular Surgery at Shore Memorial Hospital and Medical Director of the Cardiovascular Institute, a multidisciplinary department which includes vascular surgeons,...
Steven Fishbane, MDChief of Nephrology, Medical Director
Winthrop-University Hospital Inc
Steven Fishbane, MD, is Professor of Medicine at the State University of New York at Stony Brook School of Medicine. Additionally, Dr. Fishbane serves as Chief of Nephrology, Associate Chairman of the Department of Medicine, and Director of End-Stage Renal Disease Research at Winthrop-University Hospital...
Chief, Division of Nephrology
Stanford University School of Medicine
Glenn Chertow, MD, MPH, is Professor of Medicine and Chief, Division of Nephrology, at Stanford University School of Medicine and Director of Nephrology Services at Stanford Hospital and Clinics. His research interests are focused on epidemiology, health services research, and clinical trials in acute...
Richard Amerling, MDDirector of Outpatient Dialysis
BETH ISRAEL MEDICAL CENTER INC
Richard Amerling, MD, is Director of Outpatient Dialysis and Continuous Renal Replacement Therapy at the Beth Israel Medical Center in New York City, since June 1990. Dr. Amerling has an extensive background in all aspects of consultative nephrology including hypertension, kidney stones, glomerular...
Medical Director
Davita Los Angeles Dialysis Center
Jack Rubin, MD, is Medical Director of the Los Angeles Vascular Access Center (LAVAC) in Inglewood, California. LAVAC does out patient procedures to correct problems with vascular accesses in dialysis patients. LAVAC also does out-patient angiograms of the legs and repairs stenoses of femoral arteries...
Medical Director
The Rogosin Institute Inc
Jeffrey Silberzweig, MD, is Medical Director of The Rogosin Institute's Manhattan Dialysis Center and the New York Presbyterian Hospital's Inpatient Dialysis Unit as well as the Co-Director of The Rogosin Institute Queens Dialysis Center. He is also a faculty member at Cornell University Medical College....
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Considering the effects of fosamax and other bisphosphonates on bone remodeling, it is not at all surprising to see problems arising with the long term use of these agents.
It's intresting that nowhere in this article was the topic of true insurance for catastrophic illness brought up. The problem with our current health insurance market is that for most it is pre-paid care, not insurance against a rare, but catastrophic, event.
With the pipeline for new drugs running dry, it is no surprise that pharmaceutical companies are looking to expand indications for existing products still under patent protection. What better way to do this than by creating entirely new patient populations out of whole cloth?
While no more would argue that control of systolic hypertension is crucial to preventing the consequences of hypertension such as congestive heart failure, MI's, left ventricular hyperthrophy, stroke and kidney failure there are other factors that are associated with these disease states. One of these...
This article brings more visibility to issue of effect of angiogenesis inhibitors on kidney function Other mechanisms of injury have previously been described. Current case simply adds visibility and more definitive evidence of effect in humans Mechanism described is likely not restricted...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Other Freestanding Healthcare Facility
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Physician - Division Head
- Medical Director
- Partner
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

